precursor frequencies allogeneic bone marrow recipients at the level of cytotoxic T-cell Studies on the mechanism of tolerance or graft-versus-host disease in
暂无分享,去创建一个
[1] A. Deisseroth,et al. Bone marrow transplantation for leukemia. , 1993, The Journal of pediatrics.
[2] A. Zwinderman,et al. EFFECTOR MECHANISMS IN GRAFT‐VERSUS-HOST DISEASE IN RESPONSE TO MINOR HISTOCOMPATIBILITY ANTIGENS: I. ABSENCE OF CORRELATION WITH CYTOTOXIC EFFECTOR CELLS , 1990, Transplantation.
[3] B. Dupont,et al. Both ongoing suppression and clonal elimination contribute to graft-host tolerance after transplantation of HLA mismatched T cell-depleted marrow for severe combined immunodeficiency. , 1990, Journal of immunology.
[4] C. Huber,et al. Studies of the mechanism of tolerance induced by short-term immunosuppression with cyclosporine in high-risk corneal allograft recipients. I. Analysis of CTL precursor frequencies. , 1989, Transplantation.
[5] S. Mackinnon,et al. Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation. , 1989, Transplantation.
[6] H. Sollinger,et al. Enhancement of thyroid allograft survival following organ culture. Alteration of tissue immunogenicity. , 1989, Transplantation.
[7] D. Sachs,et al. MECHANISMS OF SUPPRESSION IN MIXED ALLOGENEIC CHIMERAS , 1988, Transplantation.
[8] D. Niederwieser,et al. IFN-mediated induction of MHC antigen expression on human keratinocytes and its influence on in vitro alloimmune responses. , 1988, Journal of immunology.
[9] C. Schmidt,et al. Treatment of acute graft-versus-host disease after HLA-partially matched marrow transplantation with a monoclonal antibody (BMA031) against the T cell receptor. First results of a phase-I/II trial. , 1988, Onkologie.
[10] J. Pepper,et al. Rat heterotopic heart transplantation: quantification and analysis of cell mediated cytotoxicity. , 1988, Clinical and experimental immunology.
[11] H. Deeg,et al. Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] E. Thomas,et al. Marrow transplantation for malignant disease. , 1987, The American journal of the medical sciences.
[13] W. Herzog,et al. SELECTIVE REDUCTION OF DONOR‐SPECIFIC CYTOTOXIC T LYMPHOCYTE PRECURSORS IN PATIENTS WITH A WELL‐FUNCTIONING KIDNEY ALLOGRAFT , 1987, Transplantation.
[14] A. Landay,et al. CHARACTERIZATION OF CIRCULATING SUPPRESSOR T LYMPHOCYTES IN BONE MARROW TRANSPLANT RECIPIENTS , 1987, Transplantation.
[15] B. Chapuis,et al. Detection of anti-non-MHC-directed T cell reactivity following in vivo priming after HLA-identical marrow transplantation and following in vitro priming in limiting dilution cultures. , 1987, Transplantation proceedings.
[16] M. López-Botet,et al. Defective interleukin 2 receptor expression is associated with the T cell disfunction subsequent to bone marrow transplantation , 1987, European journal of immunology.
[17] J. Meyers. Infection in bone marrow transplant recipients. , 1986, The American journal of medicine.
[18] H. Gerhartz,et al. In vivo differentiation of leukaemic blasts and effect of low dose Ara‐C in a marrow grafted patient with leukaemic relapse , 1986, British journal of haematology.
[19] H. Deeg,et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. , 1986, The New England journal of medicine.
[20] L. Strijbosch,et al. Analysis of cytotoxic T lymphocyte response in rejecting allografted canine kidneys. , 1986, Transplantation.
[21] Jaap M Middeldorp,et al. Cytomegalovirus immunity in allogeneic marrow grafting. , 1985, Transplantation.
[22] R. Storb,et al. Marrow transplantation from related donors other than HLA-identical siblings. , 1985, The New England journal of medicine.
[23] G Opelz,et al. CORRELATION OF HLA MATCHING WITH KIDNEY GRAFT SURVIVAL IN PATIENTS WITH OR WITHOUT CYCLOSPORINE TREATMENT: FOR THE COLLABORATIVE TRANSPLANT STUDY , 1985, Transplantation.
[24] C. Orosz,et al. ASSESSMENT OF IMMUNOCOMPETENCE BY LIMITING DILUTION ANALYSIS IN LONG‐TERM T CELL DEPLETION CHIMERAS TRANSPLANTED ACROSS THE MHC BARRIER , 1985, Transplantation.
[25] S. Slavin,et al. Functional clonal deletion versus active suppression in transplantation tolerance induced by total-lymphoid irradiation. , 1985, Transplantation.
[26] R. Storb,et al. Cellular interactions in marrow-grafted patients. III. Normal interleukin 1 and defective interleukin 2 production in short-term patients and in those with chronic graft-versus-host disease. , 1985, Transplantation.
[27] R. Mertelsmann,et al. Defective interleukin 2 production in patients after bone marrow transplantation and in vitro restoration of defective T lymphocyte proliferation by highly purified interleukin 2. , 1984, Blood.
[28] W. Friedrich,et al. IMMUNORECONSTITUTION IN SEVERE COMBINED IMMUNODEFICIENCY AFTER TRANSPLANTATION OF HLA-HAPLOIDENTICAL, T-CELL-DEPLETED BONE MARROW , 1984, The Lancet.
[29] D. Fradelizi,et al. Inhibiton of IL 2 production after human allogeneic bone marrow transplantation. , 1983, Journal of immunology.
[30] J. Vilček,et al. Gamma interferon synthesis by human thymocytes and T lymphocytes inhibited by cyclosporin A. , 1983, Science.
[31] R. Storb,et al. Allogeneic Bone‐Marrow Transplantation , 1983, Immunological reviews.
[32] J. Gratama,et al. A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host disease , 1983, Nature.
[33] K. Sullivan,et al. Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease. , 1982, Blood.
[34] K. Lafferty,et al. Inhibition of T‐Cell Activity by Cyclosporin A , 1982, Scandinavian journal of immunology.
[35] R. Storb,et al. Specific suppressor cells in graft–host tolerance of HLA-identical marrow transplantation , 1981, Nature.
[36] C. Taswell,et al. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. , 1981, Journal of immunology.
[37] M. Bevan,et al. Anti-recipient cytotoxic T lymphocyte precursors are present in the spleens of mice with acute graft versus host disease due to minor histocompatibility antigens. , 1981, Journal of immunology.
[38] M. Röllinghoff,et al. Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2 , 1981, European journal of immunology.
[39] B. Speck. Bone marrow transplantation in leukaemia (review). , 1981, Anticancer research.
[40] C. Huber,et al. Surface properties and in vitro functional capacities of human T lymphocyte subsets separated by linear density gradients. , 1979, Journal of immunology.
[41] David Gottlieb,et al. Mechanism of Action , 2012, Antibiotics.